Bimzelx (bimekizumab) - UCB
Cosentyx (secukinumab) - Novartis
povorcitinib (INCB54707) - Incyte
izokibep (ABY-035) - ACELYRIN
Rinvoq (upadacitinib) - AbbVie
eltrekibart (LY3041658) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/38574201
 
Austinn Miller; Michael Bernhardt; Parastou Shahzeidi
 
Apr 4, 2024
 
Prev Next